Rokos Capital Management LLP Takes Position in Corteva, Inc. $CTVA

Rokos Capital Management LLP purchased a new stake in shares of Corteva, Inc. (NYSE:CTVA) during the 1st quarter, Holdings Channel reports. The fund purchased 50,000 shares of the company’s stock, valued at approximately $4,186,000.

A number of other institutional investors have also added to or reduced their stakes in CTVA. Drummond Knight Asset Management Pty Ltd bought a new position in Corteva in the fourth quarter valued at about $25,713,000. Arbejdsmarkedets Tillaegspension bought a new stake in shares of Corteva during the fourth quarter worth about $23,679,000. Leonteq Securities AG acquired a new position in shares of Corteva in the fourth quarter valued at approximately $2,350,000. Mirae Asset Global Investments Co. Ltd. raised its holdings in Corteva by 23.5% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,075 shares of the company’s stock valued at $7,378,000 after buying an additional 20,957 shares during the last quarter. Finally, Brandes Investment Partners LP raised its holdings in Corteva by 1.1% in the 4th quarter. Brandes Investment Partners LP now owns 2,312,515 shares of the company’s stock valued at $155,009,000 after buying an additional 24,985 shares during the last quarter. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Stock Down 1.8%

Shares of NYSE CTVA opened at $87.67 on Tuesday. The company’s 50 day moving average price is $81.52 and its 200-day moving average price is $79.12. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $89.39. The company has a market capitalization of $58.64 billion, a P/E ratio of 51.57, a price-to-earnings-growth ratio of 2.70 and a beta of 0.56.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, topping the consensus estimate of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The company had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. During the same period in the prior year, the company posted $1.13 earnings per share. Corteva’s revenue for the quarter was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities analysts forecast that Corteva, Inc. will post 3.76 earnings per share for the current year.

Corteva Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Tuesday, September 1st. Corteva’s dividend payout ratio (DPR) is presently 42.35%.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the stock. BNP Paribas Exane boosted their target price on shares of Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. Rothschild & Co Redburn raised their price target on shares of Corteva from $80.00 to $90.00 and gave the company a “neutral” rating in a research note on Wednesday, April 29th. Wells Fargo & Company lifted their price target on shares of Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a report on Tuesday, April 21st. Argus boosted their price objective on shares of Corteva from $80.00 to $91.00 and gave the stock a “buy” rating in a research note on Tuesday, March 31st. Finally, UBS Group decreased their price objective on Corteva from $90.00 to $86.00 and set a “neutral” rating for the company in a report on Tuesday, June 9th. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $90.19.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.